About
Liberate Bio develops gene therapy delivery technologies using their RAPTOR™ platform to enable genetic medicines to target specific cell populations in vivo, focusing on treating hematologic cancers and autoimmune diseases.
Explore Liberate Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.